Skip to main content
Clinical Trials/NL-OMON27559
NL-OMON27559
Recruiting
Not Applicable

Tailoring Limb length based on total small bowel length in omega-loop gastric bypass

Medisch Center Leeuwarden0 sites212 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
<p>class III obesity or class II with co-morbidities e.g diabetes, hypertension, sleep apnea, arthrosis</p>
Sponsor
Medisch Center Leeuwarden
Enrollment
212
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Medisch Center Leeuwarden

Eligibility Criteria

Inclusion Criteria

  • Agreed to have mini\-gastric bypass surgery
  • \- Age between 18 and 65
  • \-BMI \> 40 kg/m2 or
  • \-BMI \> 35 kg/m2 with co\-morbidity : diabetes, hypertension, OSAS, arthrosis
  • \-Willing to participate with written informed consent before start of the surgery
  • \-A completely measured total small bowel during surgery
  • \-No pre\-operative deficiencies of vit B12, vit D and iron, measured with ferritin
  • \-No use of extra (multi\-)vitamin supplements with exception of vit D max 800 IU/day
  • \-Able to swallow the multivitamin FFM WLS primo (tested before surgery)

Exclusion Criteria

  • \-BMI \> 50 Kg/m2
  • \-Known gastro\-intestinal disease or history of gastro\-intestinal disease, e.g. celiac disease, inflammatory bowel disease
  • \-Known addiction behaviour
  • \-Suspected compliance problems
  • \-Intolerance to Fitforme Primo multivitamin
  • \-Pregnancy planning within the first two years after surgery
  • \-Renal or hepatic insufficiency
  • \-Former abdominal surgery unabling the measurement of the small bowel during laparoscopic surgery
  • \-Parenteral use of vit B12

Outcomes

Primary Outcomes

Not specified

Similar Trials